These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3141692)

  • 1. An erroneous apolipoprotein E-3 band in high density lipoprotein fractions.
    Rawlings AV; Deegan T
    J Inherit Metab Dis; 1988; 11 Suppl 2():135-8. PubMed ID: 3141692
    [No Abstract]   [Full Text] [Related]  

  • 2. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
    Ghiselli G; Schaefer EJ; Gascon P; Breser HB
    Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.
    Holmquist L
    Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of analytical isoelectric focusing in polyacrylamide gel in the diagnosis of lipid and lipoprotein metabolism disorders].
    Votruba T; Choluj B; KlestincovĂĄ J; KormĂșth E
    Cas Lek Cesk; 1987 Jul; 126(30):948-50. PubMed ID: 3652152
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Ghiselli G; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1984 Jul; 794(2):333-9. PubMed ID: 6428460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
    Janus ED; Grant S; Lintott CJ; Wardell MR
    Atherosclerosis; 1985 Nov; 57(2-3):249-66. PubMed ID: 3866582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
    Borghini I; James RW; Pometta D
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.
    Falko JM; Schonfeld G; Witztum JL; Kolar JB; Weidman SW; Steelman R
    J Clin Endocrinol Metab; 1980 Mar; 50(3):521-8. PubMed ID: 7358833
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA; Gregg RE; Sprecher DL; Brewer HB
    Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.
    Hazzard WR; Warnick GR; Utermann G; Albers JJ
    Metabolism; 1981 Jan; 30(1):79-88. PubMed ID: 7464557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference by pro-apolipoprotein A-I in apolipoprotein E phenotyping using chemical precipitation procedures.
    Rawlings AV; Deegan T
    Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():638-44. PubMed ID: 3254104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoproteins and lipoprotein families in familial lecithin: cholesterol acyltransferase deficiency.
    Alaupovic P; McConathy WJ; Curry MD; Magnani HN; Torsvik H; Berg K; Gjone E
    Scand J Clin Lab Invest Suppl; 1974; 137():83-7. PubMed ID: 4367607
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma lipoprotein metabolism in familial lecithin:cholesterol acyltransferase deficiency.
    Glomset JA; Norum KR; Nichols AV; Forte T; King WC; Albers J; Mitchell CD; Applegate KR; Gjone E
    Scand J Clin Lab Invest Suppl; 1974; 137():165-72. PubMed ID: 4367614
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.